| Name | Title | Contact Details |
|---|
Digi Security Systems, LLC, provides low-voltage, high-end security systems to commercial organizations, including schools, businesses, government institutions, hospitals, and more. Our physical systems include video surveillance, access control, CCTV, VOIP, fire alarms, and burglar alarms. The software that drives our systems provides detection analytics, facial recognition, AI integration, and more. All the systems we provide are customized to meet the unique needs of the organizations we serve. It is our privilege to provide security and technology solutions to enterprises around the country – and beyond. We take pride in the excellence of our people and the service we offer to our partners because people are our purpose. With more than 20 years in the security industry, we are a trusted technology partner for schools, universities, financial institutions, manufacturing facilities, state facilities, hospitals and more. We work every day to create a whole new meaning around customer experience in technology. Our headquarters are in Tulsa, and we have offices in Oklahoma City, Oklahoma and Dallas, Texas. Our goal is to provide organizations, big and small, with security systems that allow those using them, and those who benefit from them, to thrive. TERO – PROUDLY NATIVE OWNED | OK LIC #245765 | TX LIC #B03018601
Learn more about our 100G Symmetrical, geo-redundant fiber optic network built for Kentuckys future. We provide access to a state of the art fiber optic network delivering fast data services.
Mitchell and Titus, LLP is one of the leading companies in Business Services industry. Mitchell and Titus, LLP is based in New York, NY. You can find more information on Mitchell and Titus, LLP at www.mitchelltitus.com
Viridian Therapeutics, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2006. Formerly known as Miragen Therapeutics, the company rebranded in January 2021. Viridian is dedicated to discovering, developing, and commercializing treatments for serious and rare diseases, utilizing its expertise in antibody discovery and protein engineering. The company’s product pipeline includes Veligrotug (VRDN-001), a monoclonal antibody in Phase 3 clinical trials for thyroid eye disease, and VRDN-003, a next-generation IGF-1R monoclonal antibody also in Phase 3 trials for the same condition. Additionally, Viridian is developing a portfolio of engineered anti-FcRn inhibitors, such as VRDN-006 and VRDN-008, aimed at treating various autoimmune diseases. Viridians mission is to deliver transformative therapies for patients with underserved diseases, emphasizing innovation and patient-centricity.
The Regan Group is a Hawthorne, CA-based company in the Business Services sector.